日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prebiotic Treatment in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)-A Randomized Pilot Trial.

益生元治疗非酒精性脂肪肝病(NAFLD)患者——一项随机试点试验

Reshef Naama, Gophna Uri, Reshef Leah, Konikoff Fred, Gabay Gila, Zornitzki Taiba, Knobler Hilla, Maor Yaakov

Liraglutide-Induced Hepatotoxicity

利拉鲁肽引起的肝毒性

Maor, Yaakov; Ergaz, David; Malnick, Stephen D H; Melzer, Ehud; Neuman, Manuela G

Domain-Scan: Combinatorial Sero-Diagnosis of Infectious Diseases Using Machine Learning

Domain-Scan:利用机器学习进行传染病组合血清学诊断

Hada-Neeman, Smadar; Weiss-Ottolenghi, Yael; Wagner, Naama; Avram, Oren; Ashkenazy, Haim; Maor, Yaakov; Sklan, Ella H; Shcherbakov, Dmitry; Pupko, Tal; Gershoni, Jonathan M

Alcoholic Liver Disease: Role of Cytokines

酒精性肝病:细胞因子的作用

Neuman, Manuela G; Maor, Yaakov; Nanau, Radu M; Melzer, Ehud; Mell, Haim; Opris, Mihai; Cohen, Lawrence; Malnick, Stephen

Ashkenazi Jewish origin protects against formation of antibodies to infliximab and therapy failure

阿什肯纳兹犹太血统可预防英夫利昔单抗抗体的产生和治疗失败。

Ungar, Bella; Haj-Natour, Ola; Kopylov, Uri; Yavzori, Miri; Fudim, Ella; Picard, Orit; Loebstein, Ronen; Lahat, Adi; Maor, Yaakov; Avidan, Benjamin; Lang, Alon; Weiss, Batia; Chowers, Yehuda; Eliakim, Rami; Ben-Horin, Shomron